Diana Locsin Verdeflor, APRN | |
1009 Charity St, Abbeville, LA 70510-5302 | |
(337) 893-3443 | |
Not Available |
Full Name | Diana Locsin Verdeflor |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 22 Years |
Location | 1009 Charity St, Abbeville, Louisiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073569638 | NPI | - | NPPES |
1136727 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | RN093366 (Louisiana) | Secondary |
363LF0000X | Nurse Practitioner - Family | AP04079 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Abbeville General Hospital | Abbeville, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Iberia Comprehensive Community Health Center Inc | 6204817828 | 36 |
News Archive
CQ HealthBeat reports that Richard Gilfillan, a former head of the Geisinger Health Plan in Pennsylvania, will run the Center for Medicare and Medicaid Services Innovation Center that was created by the health law. Gilfillan was chosen Monday. At Geisinger, Gilfillan ran a plan that "many health policy analysts see as a national model for delivering quality, affordable care" (Reichard, 9/27).
GeneGo, Inc., a leading provider of software and databases for systems biology, today announced that the Indiana Clinical and Translational Sciences Institute has licensed its pathway analysis suite MetaCore and its database searching tool Eureka.
Never make a decision when you are hungry. The hormone ghrelin - that is released before meals and known to increase appetite - has a negative effect on both decision making and impulse control. Such were the results of a recently conducted study at Sahlgrenska University.
Understanding the brain has been one of science's greatest challenges. Each discovery only seems to raise countless other questions about the inner workings of this incredibly complex organ.
Alkermes, Inc. today announced the initiation of a phase 2 clinical study of ALKS 33, an investigational oral opioid modulator for the potential treatment of alcohol dependence and other central nervous system disorders. The study will assess the safety and efficacy of multiple doses of ALKS 33 in patients with alcohol dependence and is designed to further define the clinical profile of ALKS 33.
› Verified 6 days ago
Entity Name | Iberia Comprehensive Community Health Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922046549 PECOS PAC ID: 6204817828 Enrollment ID: O20050809000029 |
News Archive
CQ HealthBeat reports that Richard Gilfillan, a former head of the Geisinger Health Plan in Pennsylvania, will run the Center for Medicare and Medicaid Services Innovation Center that was created by the health law. Gilfillan was chosen Monday. At Geisinger, Gilfillan ran a plan that "many health policy analysts see as a national model for delivering quality, affordable care" (Reichard, 9/27).
GeneGo, Inc., a leading provider of software and databases for systems biology, today announced that the Indiana Clinical and Translational Sciences Institute has licensed its pathway analysis suite MetaCore and its database searching tool Eureka.
Never make a decision when you are hungry. The hormone ghrelin - that is released before meals and known to increase appetite - has a negative effect on both decision making and impulse control. Such were the results of a recently conducted study at Sahlgrenska University.
Understanding the brain has been one of science's greatest challenges. Each discovery only seems to raise countless other questions about the inner workings of this incredibly complex organ.
Alkermes, Inc. today announced the initiation of a phase 2 clinical study of ALKS 33, an investigational oral opioid modulator for the potential treatment of alcohol dependence and other central nervous system disorders. The study will assess the safety and efficacy of multiple doses of ALKS 33 in patients with alcohol dependence and is designed to further define the clinical profile of ALKS 33.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Diana Locsin Verdeflor, APRN 206 Buffalo Run, Lafayette, LA 70503-6604 Ph: (337) 988-5768 | Diana Locsin Verdeflor, APRN 1009 Charity St, Abbeville, LA 70510-5302 Ph: (337) 893-3443 |
News Archive
CQ HealthBeat reports that Richard Gilfillan, a former head of the Geisinger Health Plan in Pennsylvania, will run the Center for Medicare and Medicaid Services Innovation Center that was created by the health law. Gilfillan was chosen Monday. At Geisinger, Gilfillan ran a plan that "many health policy analysts see as a national model for delivering quality, affordable care" (Reichard, 9/27).
GeneGo, Inc., a leading provider of software and databases for systems biology, today announced that the Indiana Clinical and Translational Sciences Institute has licensed its pathway analysis suite MetaCore and its database searching tool Eureka.
Never make a decision when you are hungry. The hormone ghrelin - that is released before meals and known to increase appetite - has a negative effect on both decision making and impulse control. Such were the results of a recently conducted study at Sahlgrenska University.
Understanding the brain has been one of science's greatest challenges. Each discovery only seems to raise countless other questions about the inner workings of this incredibly complex organ.
Alkermes, Inc. today announced the initiation of a phase 2 clinical study of ALKS 33, an investigational oral opioid modulator for the potential treatment of alcohol dependence and other central nervous system disorders. The study will assess the safety and efficacy of multiple doses of ALKS 33 in patients with alcohol dependence and is designed to further define the clinical profile of ALKS 33.
› Verified 6 days ago
Mrs. Teddi Poche' Willis, APRN, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2305 Richard St, Abbeville, LA 70510 Phone: 337-892-9800 | |
Natalie Mccall, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 118 N Hospital Dr, Abbeville, LA 70510 Phone: 337-898-6419 | |
Mary Ricaud Leblanc, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2615 North Dr, Abbeville, LA 70510 Phone: 337-893-1506 | |
Mrs. Crystal Hancox, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2419 Alonzo St, Abbeville, LA 70510 Phone: 337-892-0630 | |
Haley Miller, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 121 E Saint Victor St, Abbeville, LA 70510 Phone: 337-893-0810 | |
Torie Tauzin, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2421 Alonzo St, Abbeville, LA 70510 Phone: 337-892-6919 |